In 2020-2021, An Ultra-Soft Monetary Policy Was Carried Out, Which Cassed an iPo Boom. MANY BIOTECH Companies have Gained Access to the Capital Markets Without Having Finished Products (Only Research and Development) Or Revenue.

To Finance the Work, These Cash-Burning Companies Regularly Raidition Capital in the Market. However, it is Difficult to Attract Outside Capital Now, As Rates Have Risen and Risk Appetite Has Decline.

as a Result, Some of these Firms Ares Aut by Large Players IS A Product with Proven Effectivence in the Later Stages of Research. The Other Part Is Forced to Go Bankrup.

Pharmaceutical Companies Field 84% More Bankrupy Filings in 2022 That Year Earlier, According to A Report by Consulting Firm Gibbins Advisors.

How to make money on this?

When A Company IS Liquided, After Repayment of All Liabilites, The Remaining Funds Are Distributed Among The Shareholders.

Offten the Shares of Such Firms are Tradeed Cheaper than the Value of Net Assets (All Property Minus All Liabilites). In Other Words, An Investor Can Buy Shares for Less than Their Liquidation Value. Once The Liquidation is Complete, The Investor Can Earn a Significant Return.

The Return Corresponds to the Difference Between The Share Price and the Net Asset Value After Liquidation. Offten the Yield Exceleds 100%. The Main Task of the Investor is to Correctly Estimate the Liquidation Value and Make Sure that Current Share Price Is Lower.

ExamPles

📎 Cyteir Was Unable to Continue The Development of a Drug for Oncology, and Deceded to Liquidate it. The Company Traded At a Discount to Cash on the Balance Sheet at $ 1.62 per share. AFTER The Liquidation Was OFICILALLY Announced, Cyteir's Shares Jumped 39% TO $ 2.26 and Continood to Rise to $ 2.67. At the Same Time, During the Distribution, Investors Can Count on Another 25% Return.

📎 Sio Gene Therapies Traded at a 50% DISCOUNT To CASH ON BALANCE. AFTER Management Announced the Liquidation, The Stock Rose 42% from $ 0.28. At a Current Value of $ 0.4, The Payut is Expicted to be $ 0.51, Implying a yield of 28%.

OUR Portfolio Currently Includes One Liquidation Company with A Potential Upside of 100%. However, We are Actively Looking at New Opportunites.